Panel Discussion: Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact

• Examining recent advances across degrader and non-degrader modalities, highlighting how new discoveries are moving the field beyond oncology
• Assessing the influence of global markets, including China, on drug development, the clinical landscape and strategic collaborations in induced proximity therapeutics
• Identifying emerging opportunities, bottlenecks, and the next frontiers in translating platform innovations into clinically relevant therapies

Speakers:

Ryan Potts

Vice President, Research

Amgen Inc.

Arthur Sands

Chief Executive Officer

Nurix Therapeutics, Inc.

Paige Mahaney

Chief Scientific Officer

C4 Therapeutics Inc

Adrian Gottschalk

President & Chief Executive Officer

Foghorn Therapeutics

Eddine Saiah

Chief Executive Officer

Stablix